
Abigail Louise Vanhorn
Examiner (ID: 16074)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1616, 1609, 1636 |
| Total Applications | 1398 |
| Issued Applications | 583 |
| Pending Applications | 147 |
| Abandoned Applications | 713 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18675553
[patent_doc_number] => 20230313161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/153490
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153490 | DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF | Jan 11, 2023 | Pending |
Array
(
[id] => 19297414
[patent_doc_number] => 20240225979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => COMPOSITIONS, FORMULATIONS, AND METHODS FOR HAIR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/092517
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/092517 | Compositions, formulations, and methods for hair treatment | Jan 2, 2023 | Issued |
Array
(
[id] => 18784661
[patent_doc_number] => 20230372254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => FORTIFIED MICRONUTRIENT SALT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/067541
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067541
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/067541 | FORTIFIED MICRONUTRIENT SALT FORMULATIONS | Dec 15, 2022 | Abandoned |
Array
(
[id] => 18451922
[patent_doc_number] => 20230193201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES
[patent_app_type] => utility
[patent_app_number] => 18/063982
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063982 | METHODS FOR PRODUCING IMMUNE CELL CULTURES | Dec 8, 2022 | Pending |
Array
(
[id] => 18451922
[patent_doc_number] => 20230193201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES
[patent_app_type] => utility
[patent_app_number] => 18/063982
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063982 | METHODS FOR PRODUCING IMMUNE CELL CULTURES | Dec 8, 2022 | Pending |
Array
(
[id] => 18451922
[patent_doc_number] => 20230193201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES
[patent_app_type] => utility
[patent_app_number] => 18/063982
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063982 | METHODS FOR PRODUCING IMMUNE CELL CULTURES | Dec 8, 2022 | Pending |
Array
(
[id] => 18404439
[patent_doc_number] => 20230165789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
[patent_app_type] => utility
[patent_app_number] => 18/076023
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076023
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076023 | IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE | Dec 5, 2022 | Pending |
Array
(
[id] => 18389920
[patent_doc_number] => 20230158138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/058513
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/058513 | MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME | Nov 22, 2022 | Pending |
Array
(
[id] => 18266178
[patent_doc_number] => 20230087420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/992783
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992783 | CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY | Nov 21, 2022 | Abandoned |
Array
(
[id] => 18522887
[patent_doc_number] => 20230233536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/053865
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053865
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053865 | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | Nov 8, 2022 | Issued |
Array
(
[id] => 18583177
[patent_doc_number] => 20230265437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 18/048577
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048577
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048577 | RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use | Oct 20, 2022 | Pending |
Array
(
[id] => 18449387
[patent_doc_number] => 20230190663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/950573
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950573 | PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF | Sep 21, 2022 | Pending |
Array
(
[id] => 18449387
[patent_doc_number] => 20230190663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/950573
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950573 | PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF | Sep 21, 2022 | Pending |
Array
(
[id] => 18581656
[patent_doc_number] => 20230263910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/933937
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/933937 | AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM | Sep 20, 2022 | Pending |
Array
(
[id] => 19195361
[patent_doc_number] => 11992580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Method of soft tissue augmentation
[patent_app_type] => utility
[patent_app_number] => 17/941713
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5379
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941713 | Method of soft tissue augmentation | Sep 8, 2022 | Issued |
Array
(
[id] => 19792365
[patent_doc_number] => 12233289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Methods for fixing hair and skin
[patent_app_type] => utility
[patent_app_number] => 17/941675
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15183
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941675 | Methods for fixing hair and skin | Sep 8, 2022 | Issued |
Array
(
[id] => 18550883
[patent_doc_number] => 20230248884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/929886
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929886 | COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION | Sep 5, 2022 | Abandoned |
Array
(
[id] => 18107994
[patent_doc_number] => 20230000874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PEMETREXED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/898558
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898558
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898558 | PEMETREXED FORMULATIONS | Aug 29, 2022 | Abandoned |
Array
(
[id] => 18091282
[patent_doc_number] => 20220409623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PEMETREXED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/898637
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898637 | PEMETREXED FORMULATIONS | Aug 29, 2022 | Abandoned |
Array
(
[id] => 18091283
[patent_doc_number] => 20220409624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PEMETREXED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/898984
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898984 | PEMETREXED FORMULATIONS | Aug 29, 2022 | Abandoned |